ANETTA REMELSKI: Open Payments
NPI 1861162448 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 35 payments from 15 companies in 2025. Trend: 2023 $530 · 2024 $494 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $182 |
| Lilly USA, LLC | 5 | $152 |
| BIOTISSUE HOLDINGS INC. | 1 | $139 |
| Dexcom, Inc. | 1 | $122 |
| PFIZER INC. | 4 | $68 |
| Boston Scientific Corporation | 1 | $40 |
| SCILEX PHARMACEUTICALS INC. | 2 | $34 |
| Intra-Sana Laboratories | 2 | $31 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| BIOTRONIK NRO, Inc. | 1 | $29 |
Products named: Wegovy, MOUNJARO, Dexcom G6 Transmitter, NURTEC ODT, AMS 700, ZTLido, RELTONE 200 MG, CONTRAVE.
Industry payments across NJ — which companies pay providers there.
